Tom Bulford examines five common mistakes that private investors make, and explains how you can avoid them.
Articles written by Tom Bulford
Bacteria are becoming increasingly resistant to antibiotics – the biotech firms developing alternatives are set to profit handsomely, says Tom Bulford.
Human body parts can now be ‘printed’ to replace defective ones. Tom Bulford looks at this exciting new technology, and focuses on one small-cap company making remarkable advances.
A mushroom known to the Chinese for millennia has become the latest weapon in the fight against cancer. Tom Bulford reports on the small-cap pharma leading the research.
There are many great reasons to invest in penny shares. But as Tom Bulford explains, buying just because they cost pennies isn’t one of them.
Research into biotechnology is as exciting as it is important, says Tom Bulford. And for smart investors, it can also mean big profits.
When it comes to the thrill of investing in cutting-edge companies, you can’t do better than penny shares. Tom Bulford looks back at some of his past triumphs.
It’s no good savers complaining that interest rates are low, says Tom Bulford. If you want to grow your money, you have to do it yourself.
Tom Bulford looks at who would win and who would lose should the price of oil slump to $50 a barrel.
This small-cap medical devices company has attracted the attention of two big American pharmaceutical giants, says Tom Bulford. And it’s not hard to see why.